Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bromocriptine treatment of hyperprolactinemia].

J Gauer, H J Heberling, B Stubert

    Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
    |July 1, 1985
    PubMed
    Summary

    Bromocriptine effectively normalizes prolactin (PRL) levels in patients with microprolactinoma and hyperprolactinemia. This treatment leads to improved menstrual cycles, reduced galactorrhea, and increased conception rates, with manageable side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Retinoblastoma].

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2020
    Same author

    [Uveal melanoma: current insights into clinical relevance of genetic testing].

    Klinische Monatsblatter fur Augenheilkunde·2013
    Same author

    Current concepts for diagnosis and treatment of retinoblastoma in Germany: aiming for safe tumor control and vision preservation.

    Klinische Padiatrie·2012
    Same author

    [New developments in molecular genetics and treatment of retinoblastoma].

    Klinische Monatsblatter fur Augenheilkunde·2011
    Same author

    Characterization and comparison of shear and extensional flow of sodium hyaluronate and human synovial fluid.

    Biorheology·2010
    Same author

    Meningioma 40 years after radiation therapy for retinoblastoma: genetic and phenotypic analysis, and minireview of literature.

    Zentralblatt fur Neurochirurgie·2008

    Area of Science:

    • Endocrinology
    • Pharmacology

    Context:

    • Hyperprolactinemia, often caused by microprolactinoma, disrupts reproductive health.
    • Postoperative residual hyperprolactinemia requires effective treatment.

    Purpose:

    • To evaluate the efficacy of bromocriptine in treating microprolactinoma and persistent hyperprolactinemia.
    • To assess bromocriptine's impact on hormonal levels, menstrual cycles, galactorrhea, and conception.

    Summary:

    • Bromocriptine therapy normalized prolactin (PRL) levels in microprolactinoma patients.
    • Significant improvements were observed in 80% of women with normalized cycles, 90% with reduced galactorrhea, and nearly two-thirds achieving conception.
    • Secondary therapy with bromocriptine also effectively lowered PRL levels in nearly 80% of patients with persistent hyperprolactinemia.

    Impact:

    • Bromocriptine is a viable treatment for hyperprolactinemia, restoring reproductive function.
    • Long-term bromocriptine therapy may allow for dose reduction, necessitating periodic hormone level monitoring.
    • Most side effects associated with bromocriptine treatment are transient.

    Related Experiment Videos